US FDA

US FDA declines to authorise Verrica’s viral skin disease treatment

Read more

Biohaven’s drug for genetic neurological disease fails late-stage study

Read more

US FDA lifts hold on Covaxin’s clinical trials

Read more

US FDA-Gujarat FDCA Regulatory Forum to be held from 17th to 19th May

Read more

FDA declines to authorise common antidepressant as COVID treatment

Read more

Moderna completes FDA submission for use of COVID shot in adolescents, kids

Read more

Sun Pharma gets Form 483 from US FDA for regulatory violations at Halol plant

Read more

Novavax files for authorisation of COVID-19 shot among adolescents in Britain

Read more

US FDA declines to approve two more China-tested drugs

Read more

Aurobindo and Sun Pharma recall products in US market

Read more